Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F J Huff

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Journal of the American Geriatrics Society|January 1, 1987
Age at onset and rate of progression of Alzheimer's diseaseF J Huff, J H Growdon, S Corkin, et al.
Neurobiology of Aging|July 1, 1986
Piracetam combined with lecithin in the treatment of Alzheimer's diseaseJ H Growdon, S Corkin, F J Huff, et al.
Neurobiology of Aging|May 1, 1989
Prevalence of thyroid abnormalities is not increased in Alzheimer's diseaseO Lopez, F J Huff, A J Martinez, et al.
Annals of the New York Academy of Sciences|January 1, 1991
Potential clinical use of an adrenergic/cholinergic agent (HP 128) in the treatment of Alzheimer's diseaseF J Huff, P Antuono, M Murphy, et al.
Archives of General Psychiatry|October 1, 1988
Familial risk of dementia associated with a biologic subtype of Alzheimer's diseaseG S Zubenko, F J Huff, J Beyer, et al.
Biological Psychiatry|December 1, 1988
Cognitive function and platelet membrane fluidity in Alzheimer's diseaseG S Zubenko, F J Huff, J Becker, et al.
Archives of Neurology|September 1, 1987
The neurologic examination in patients with probable Alzheimer's diseaseF J Huff, F Boller, F Lucchelli, et al.
Archives of Neurology|March 1, 1988
Neuropsychological function in Alzheimer's disease. Pattern of impairment and rates of progressionJ T Becker, F J Huff, R D Nebes, et al.
Biological Psychiatry|October 1, 1988
No effect of haloperidol on cerebrospinal fluid acetylcholinesterase in patients with schizophreniaF J Huff, C T Reiter, J Rosen, et al.
Journal of the Neurological Sciences|February 1, 1986
Cholinesterases in cerebrospinal fluid. Correlations with clinical measures in Alzheimer's diseaseF J Huff, J C Maire, J H Growdon, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Journal of the American Geriatrics Society|January 1, 1987
Age at onset and rate of progression of Alzheimer's diseaseF J Huff, J H Growdon, S Corkin, et al.
Neurobiology of Aging|July 1, 1986
Piracetam combined with lecithin in the treatment of Alzheimer's diseaseJ H Growdon, S Corkin, F J Huff, et al.
Neurobiology of Aging|May 1, 1989
Prevalence of thyroid abnormalities is not increased in Alzheimer's diseaseO Lopez, F J Huff, A J Martinez, et al.
Annals of the New York Academy of Sciences|January 1, 1991
Potential clinical use of an adrenergic/cholinergic agent (HP 128) in the treatment of Alzheimer's diseaseF J Huff, P Antuono, M Murphy, et al.
Archives of General Psychiatry|October 1, 1988
Familial risk of dementia associated with a biologic subtype of Alzheimer's diseaseG S Zubenko, F J Huff, J Beyer, et al.
Biological Psychiatry|December 1, 1988
Cognitive function and platelet membrane fluidity in Alzheimer's diseaseG S Zubenko, F J Huff, J Becker, et al.
Archives of Neurology|September 1, 1987
The neurologic examination in patients with probable Alzheimer's diseaseF J Huff, F Boller, F Lucchelli, et al.
Archives of Neurology|March 1, 1988
Neuropsychological function in Alzheimer's disease. Pattern of impairment and rates of progressionJ T Becker, F J Huff, R D Nebes, et al.
Biological Psychiatry|October 1, 1988
No effect of haloperidol on cerebrospinal fluid acetylcholinesterase in patients with schizophreniaF J Huff, C T Reiter, J Rosen, et al.
Journal of the Neurological Sciences|February 1, 1986
Cholinesterases in cerebrospinal fluid. Correlations with clinical measures in Alzheimer's diseaseF J Huff, J C Maire, J H Growdon, et al.
Pageof 5